fda glp 1 shortage list issues GLP-1 'green list,' raising questions for South Florida GLP-1 No Longer on FDA's

Ecotoxicology 30:10291042

& Radwan, N

The Grey Market Problem A quick internet search for "BPC-157" returns dozens of websites selling peptides under the guise of "research use only." These vendors operate in a regulatory grey area, selling peptides technically labeled for research but clearly marketed toward human use

Unlike other antioxidants, astaxanthin has no pro-oxidant activity

In its submission to FDA, Eli Lilly and Company relied on these proposed criteria and claimed that tirzepatide, the active ingredient in Mounjaro (tirzepatide) injection and Zepbound (tirzepatide) injection, meets at least two of these proposed criteriafirst because of the complexity of its formulation, and second because of the complexity in its required physiochemical or analytical testing